Many patients come to GLP-1 therapy after following low-carb, high-fat diets, but they often find that large amounts of fat suddenly feel intolerable
Arguably, the most clinically relevant basis for the potential of GLP-1 RAs in HF could be their effect on multiple cardiometabolic parameters that play intertwined roles across the HF-related diseases such as diabetes and obesity, which often co-exist
Concurrent use of anticoagulants (warfarin, DOACs), antiplatelet agents (aspirin, clopidogrel), or NSAIDs significantly increases the risk of gastrointestinal bleeding
Adderall may also worsen mental health conditions, slow growth in children, and trigger seizures in some individuals
As GLP-1 medications continue to grow in popularity for both diabetes management and weight loss, patients are often faced with a key decision: should you take your medication as a weekly injection or a daily pill
Easily request a return label via our return form